Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.

Journal: Cancer Cell

Published: 2018-12-10

DOI: 10.1016/j.ccell.2018.10.016

Affiliations: 31

Authors: 55

Go to article
Institutions FC
Division of Cancer Epigenomics, DKFZ, Germany 0.13
Institut für Pathologie, UHH, Germany 0.13
Otto-Warburg-Laboratory, MPI-MG, Germany 0.09
EMBL Genome Biology Unit, Germany 0.08
Division of Theoretical Bioinformatics, DKFZ, Germany 0.06
Department of Urology, UT Southwestern Medical Center, United States of America (USA) 0.05
DKTK Site Heidelberg, Germany 0.05
Martini-Klinik, UHH, Germany 0.05
Finsen Laboratory, Rigshospitalet, Denmark 0.04
Biotech Research and Innovation Centre (BRIC), UCPH, Denmark 0.04
Division of Cancer Genome Research, DKFZ, Germany 0.04
NIH NIEHS Genome Integrity and Structural Biology Laboratory, United States of America (USA) 0.04
Division of Applied Bioinformatics, DKFZ, Germany 0.02
Manchester Cancer Research Centre (MCRC), United Kingdom (UK) 0.02
NIH NIEHS Integrative Bioinformatics Support Group, United States of America (USA) 0.02
Progether AS, Norway 0.02
Informatics and Bio-computing Program, OICR, Canada 0.02
Department of Bioinformatics and Functional Genomics, Uni Heidelberg, Germany 0.02
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.02
Charité - University Medicine Berlin, Germany 0.01
Ontario Institute for Cancer Research (OICR), Canada 0.01
Division of Translational Oncology, DKFZ, Germany 0.01
Department of Medical Biophysics, U of T, Canada 0.01
Division of Functional and Structural Genomics, DKFZ, Germany 0.01
Faculty of Biosciences, Uni Heidelberg, Germany 0.01
Department of Pediatric Oncology, Hematology and Immunology, Uni Heidelberg, Germany 0.01
Nordic EMBL Partnership for Molecular Medicine, Germany 0
UiO Institute for Cancer Genetics and Informatics (ICGI), Norway 0
UiO Department of Core Facilities, Norway 0
UiO Institute for Cancer Research, Norway 0

Return